Contact Us

YAZ Side Effects
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date of Birth of Person Using Yaz, Yasmin, or Ocella

Date Started Using Yaz, Yasmin, or Ocella

Date Stopped Using Yaz, Yasmin, or Ocella

Date-of-Injury : 

Did you experience any of the following complications during or after using Yaz, Yasmin, or Ocella

What injury have you suffered?

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Bayer Says 651 Yaz, Yasmin Blood Clot Lawsuits Have Been Settled

Apr 27, 2012 | Parker Waichman LLP

Bayer AG continues to settle lawsuits alleging its Yaz and Yasmin birth control pills caused serious, life-threatening blood clots in some young women.  According to the company's latest Stockholder Newsletter, Yaz and Yasmin lawsuit settlements have cost the company $142 million so far.

According to Bayer, some 651 lawsuits have been resolved. 

“Bayer is only settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case specific analysis of medical records,” the company's report said.

According to a report from Bloomberg News, around 14,000 plaintiffs have filed 11,900 lawsuits over Yaz and Yasmin.  About half of the lawsuits allege the drugs caused blood clots that can lead to heart attacks, strokes and even death.  Bayer has not indicated a willingness to settle other claims, such as those alleging use of Yaz and Yasmin led to gallbladder disease.

Most of those lawsuits are pending in a multidistrict litigation under way in Illinois federal court alleging that Yaz and Yasmin caused serious side effect injuries, including blood clots.  Late last year, the first trials in that litigation, which were scheduled to start in January, were postponed, and the cases were ordered to mediation at Bayer's request.

Earlier this month, the U.S. Food & Drug Administration (FDA) announced that the labels for Yaz, Yasmin and similar birth control pills would be updated to include additional information regarding blood clots, after its review of observational studies indicated that oral contraceptives made with drospirenone might pose a higher risk of blood clots compared to those made with other forms of progestin.

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo